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Abstract
Background: Breast cancer metastasis suppressor 1 (BRMS1) reduces the number and the size of secondary tumours in a
mouse model without affecting the growth of the primary foci upon its re-expression. Knockdown of BRMS1 expression
associates with metastasis. The molecular details on BRMS1 mechanism of action include its ability to function as a
transcriptional co-repressor and consistently BRMS1 has been described as a predominantly nuclear protein. Since cellular
distribution could represent a potential mechanism of regulation, we wanted to characterize BRMS1 sequence motifs that
might regulate its cellular distribution. According to its amino acids sequence, BRMS1 contain two putative nuclear
localization signals, however none of them has been proved to work so far.
Methodology/Principal Findings: By using well known in vivo assays to detect both nuclear import and export signal, we
have characterized, in the present study, one functional nuclear localisation signal as necessary and sufficient to promote
nuclear transport. Additionally, the outcome of a directed yeast two-hybrid assay identify importin a6 as a specific partner of
BRMS1 thus speculating that BRMS1 nuclear import could be specifically mediated by the reported nuclear transporter.
Besides, the combination of a computational searching approach along the utilization of a nuclear export assay, identified a
functional motif within the BRMS1 sequence responsible for its nuclear export, that resulted not affected by the highly
specific CRM1 inhibitor Leptomycin-B. Interspecies heterokaryon assay demonstrate the capability of BRMS1 to shuttle
between the nuclear and cytosolic compartments
Conclusions/Significance: Our results show for the first time that BRMS1 contains both nuclear import and export signals
enabling its nucleo-cytoplasmic shuttling. These findings contributes new data for the understanding of the BRMS1
functions and allow us to speculate that this phenomenon could represent a novel mechanism for regulating the activity of
BRMS1 or its associated cytosolic partners
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Introduction
Breast cancer metastasis suppressor 1 (BRMS1), one of the
members of a recently described family of proteins known as
metastasis suppressors, specifically inhibit the development of
secondary foci without affecting the growth of the primary tumour.
These results were demonstrated by ectopic expression into highly
metastatic cells in an experimental in vivo assay (reviewed in [1]).
Underlying mechanisms of action proposed for BRMS1 include
facilitation of cell-cell communication [2], interaction with HDAC
complex components [3,4,5], shutting-down of PI3K signalling [6]
and gene expression inhibition by targeting NFkB [7]. Recently,
more data have provided insight into potential new mechanism by
which BRMS1 could inhibit metastasis progression [8].
PartofthewiderangeofmolecularmechanismsinvolvingBRMS1
might be caused by its role in transcriptional repression [5,7,8,9,10].
Nuclear localisation is therefore important to perform BRMS1
cellular functions and possibly inhibit metastasis progression.
Analysis of the BRMS1 amino acid sequence identified two
coiled-coil motives at residues 51–81 and 147–180, and two
putative canonical monopartite nuclear localization signals (NLSs)
located at amino-acid residues 198–205 (NLS1) and 239–245
(NLS2). However, their functionalities have not been experimen-
tally confirmed yet, nor have been the possibility of BRMS1
diffusion to the nucleus.
Even though its expression has been largely restricted to the
nucleus, previous work [8] and unpublished data in our laboratory
have led us to raise the hypothesis of a plausible presence of
BRMS1 in the cytosol. Evidence comes from protein-protein
interaction found using FRET analyses, as well as by the
identification of cytosolic partners by yeast two-hybrid assays
(submitted). The latter results have also been shown by other
authors [11] reinforcing our conjecture. The presence of a putative
nuclear export signal (NES) capable of complementing the alleged
nuclear localisation and therefore enabling BRMS1 to shuttle
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hypothesis is correct it could imply that the activity of BRMS1
might be modulated by compartmentalisation. It would also shed
light into a new more complicated mechanism of action for its
anti-metastatic activity. Therefore, this issue represents an
important molecular question for the understanding of cancer
genetics and metastasis involving BRMS1.
The active transport of proteins through the nuclear pores is
commonly mediated by nuclear import and export receptors
belonging to the karyopherin family [12]. The transport receptors
bind to specific signals known as NLS and NES. Cargo proteins
exposing a NES are usually recognized and bound by CRM1,
mediating the export towards the cytoplasm of cellular and viral
proteins as well as ribonucleoproteins [12,13]. CRM1-mediated
export is inhibited by Leptomycine-B (LMB) [14]. Typical NES are
rich in large hydrophobic amino acids with characteristic spacing
among them [15]. So far, 67 high-confidence NES have been
reported, WX2WXW (where W=L, I, V, F, M and X is any amino-
acid) being the most conserved pattern [16] which deviates from the
previously accepted consensus WX2–3WX2–3WXW [15,17].
Protein transport towards the nucleus is determined by the
presence of a single (monopartite) or two short stretches of basic
amino acids spaced by 10–12 residues (bipartite). Monopartite
sequences are exemplified by the SV40-NLS one (PKKKRKV).
Import receptors recognize and bind cargoes in the cytosol
followed by its delivering inside the nucleus. One such import
receptor is importin a6, a nuclear transporter for NLS-containing
proteins. This protein features an N-terminal domain that is
responsible for importin b binding and necessary for nuclear
translocation through the nuclear pore, eight armadillo repeats
involved in the NLS recognition and binding, and a C-terminal
acidic region whose function remains unclear.
Here we report that the NLS1 motif of the BRMS1 protein, but
not NLS2, is necessary and sufficient for nuclear transport.
Furthermore, yeast two-hybrid results suggest that nuclear import
of BRMS1 might be mediated by importin a6. Besides, we
demonstrate that BRMS1 has the capability to migrate between
nucleus and cytoplasm and define precisely the motifs responsible
for this shuttling. A functional nuclear export sequence (NES) was
identified between residues 74–91 of BRMS1. The nuclear-
cytoplasm shuttling of BRMS1 represents a previously non-
reported, possible mechanism for regulating the activity of
BRMS1 or its associated cytosolic partners. The identified NES
is CRM1-independent, since the CRM1-inhibitor LMB did not
block the exit of exogenously expressed protein.
Results
The region of BRMS1 encompassing residues 198 to 246 is
able to transport a heterologous protein into the nucleus
We want to characterize the properties of putative nuclear
localization signals (NLSs) present within the BRMS1 protein
sequence. Although it seems possible that a protein without its own
NLS enters the nucleus via co-transport with a partner harbouring
one, many nuclear proteins encode their own NLSs.
Analysis and prediction of cellular localization signals based on
BRMS1 amino-acid sequence by the PSORT II server (http://
psort.nibb.ac.jp/form2.html) [18] reveals the presence of two
putative NLSs at residues 198–205 (PPSKRKKA) and 238–245
(PQKRKSD) fulfilling the loose consensus of the classical
monopartite NLS which requires a lysine in the P1 position
followed by basic residues in positions P2 and P4 to yield a
consensus sequence of K K/R X K/R [19].
To check whether NLS1 and NLS2 are required for BRMS1
nuclear import, we engineered truncated forms of BRMS1
(Figure 1A) and inserted them into the NLS mapping vector
pHM830 [20]. The resulting fusion protein is large enough to
prevent its passive diffusion to the nucleus, since its size is far above
the diffusion limit for the mammalian nuclear pore complex [21].
This system has extensively been used for the unambiguous
identification of the NLS activity of both conventional [20] and
non conventional import signals [22].
Constructs were transiently transfected into U2-OS cells and
GFP signal expression was analysed 24 h later. A plasmid
containing the entire BRMS1 sequence (pHM830/BRMS1 FL)
showed a diffuse staining both in the nucleus and the cytosol
(Figure 1B and Figure S1). Over-expression of a truncated version
encompassing amino-acid 2–197, thus lacking both nuclear signals
(pHM830/DNLSs), showed a diffuse distribution of fluorescence
restricted to the cytosol (Figure 1B and Figure S2). The latter
staining pattern was also observed after over-expression of
pHM830 empty vector, which is unable to import the GFP
towards the nucleus (Figure 1B and FigureS2). Interestingly, a
construct containing residues 197–246 (pHM830/NLSs) encom-
passing the two clusters of basic amino-acid was able to relocate
the fusion protein into the nucleus as efficiently as a positive
control (pHM840), containing the monopartite NLS of the SV40
(Figure 1B and Figure S2).
These data demonstrate that the C-terminal end of BRMS1
(residues 197–246) indeed contains a functional NLS, which is
necessary and sufficient to target a heterologous protein towards
the nucleus.
NLS1 is necessary and sufficient to mediate nuclear
import in an in vivo assay
To further characterize the NLSs and shed light into their
relative contributions to the nuclear import of the FL BRMS1
protein, we engineered two more constructs containing either
NLS1 (pHM830/DNLS2, encompassing residues 2–223) or NLS2
(pHM830/NLS2, harbouring residues 205 to the C-terminus) and
analyzed their cellular locations after over-expression. The fusion
protein expressed from the pHM830/NLS2 plasmid did not
migrate to the nuclear compartment, showing a sole cytosolic
location pattern. Conversely, the protein expressed from the
pHM830/DNLS2 construct displayed the characteristic pattern
revealed by the FL construct (Figure 1B and Figure S2). Taken
together these results suggest that NLS1, but not NLS2, is capable
of mediating the nuclear import of a heterologous protein,
underscoring its role as a nuclear import signal.
To precisely determine the amino acid responsible for nuclear
import, oligonucleotides encoding the KRKK sequence found within
the NLS1 region, were annealed and cloned into the pHM830 vector
(pHM830/KRKK). As shown in Figure 1B and Figure S2, upon
transient transfection of this plasmid into mammalian cells, the
expression pattern resembles that shown by the construct containing
the full NLS1 but also the one displayed by the vector encoding the
entire BRMS1. Interestingly, a construct with the fourth lysine
residue of the NLS consensus sequence replaced by an uncharged
serine (-KRKS-) as found in the putative NLS2, showed an
expression pattern indistinguishable from the one observed during
over-expression of the pHM830 empty vector, abolishing completely
the nuclear location. Altogether, these results demonstrate that NLS2
from BRMS1 does not play a role as a signal for targeting protein(s)
into the nucleus, whilst the NLS1 is necessary and sufficient for
functioning as a classical monopartite NLS.
All the over-expression experiments for NLS characterization
were also carried out in HeLa (Figure S3), and MDA-MB-231 cells
BRMS1 Nucleo-Cytosol Shuttling
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indistinguishable for those observed in U2-OS transfected cells,
thus suggesting that the NLS signal present in BRMS1 operates via
a general mechanism that is cell-type independent. Furthermore,
the expression of all these fusion proteins was verified by western
blot confirming that they were correctly synthesized, present in a
stable form and their relative molecular mass were in agreement
with the expected molecular weights values (Figure 1D).
Importin a6 but not a1 nor a3 interacts with BRMS1 in an
in vivo yeast two-hybrid assay
Different importins, also named karyopherins (KPNAs), are
known to bind several cargoes in the cytoplasm and transport them
into the nucleus. To identify the mechanism of BRMS1 nuclear
transport,weanalyzed bya yeasttwo-hybridassaytheinteractionof
BRMS1 protein with several importins, belonging to different
subfamilies based on the similarity of their primary structure [23].
To achieve this goal, the AH109 S. cerevisiae strain was co-
transformed with a yeast vector containing the BRMS1 FL
sequence (pAS2.1/BRMS1) and one of the yeast expression
plasmids encoding the entire importin a6 (pACT2/KPNA5),
importin a1 (pACT2/KPNA2) or a3 (pACT2/KPNA4). Colonies
were grown on selective agar medium lacking tryptophan and
leucine (SD-T-L) to confirm the presence of both expression
plasmids (Figure 2A). Positive colonies were re-streaked onto high
selective plates lacking histidine as a first reporter gene (SD-T-L-
H). After 4–5 days of incubation co-transformed cells over-
expressing importin a6 (KPNA5) were capable to grow
(Figure 2B). However, yeast colonies over-expressing importin
a1 (KPNA2) or importin a3 (KPNA4) failed (data not shown). A
colony-lift filter b-galactosidase assay was performed to confirm
that only those yeast cells over-expressing importin a6 and
BRMS1 showed b-Gal expression (Figure 2C). These results
suggest that full-length BRMS1 specifically interacts with KPNA5,
while it does not with the other two tested importin a transporters.
To determine whether BRMS1 protein is capable of auto-
activation, yeast cells were co-transformed with the bait protein
along with an AD empty vector, grown on selective medium (SD-T-
L-H) and further assayed for b-Gal expression. As shown in
Figure2Cnob-GalexpressionwasdetectedverifyingthatGal4BD/
BRMS1 itself does not activate transcription of any of the reporter
genes in yeast. Furthermore, AH109 strain was co-transformed with
two previously characterized interacting proteins [24] and their
interaction was used as a positive control (Figure 2A-D).
Since the N-termini of importin a proteins have been shown to
constitute auto-inhibitory domain [25,26], we generated Gal4 AD
importin a fusion proteins lacking their respective auto-inhibitory
domains and co-transformed them into yeast cells together Gal4
BD BRMS1 construct.
As shown in Figure 2B, yeast over-expressing mutated versions of
importin a1o ra3 failed to grow in the absence of histidine in the
growth media and thus were unable to express b-galactosidase in a
colony lift filter assay (Figure 2C). Interestingly, co-transformed
yeast over-expressing an N-terminal mutant of importin a6 grew in
SD-T-L-H plates at a higher extent that the FL version (Figure 2B).
In order to quantitatively measure the b-galactosidase activity of
these two positive constructs we used ONPG as a substrate in a
liquid culture colorimetric assay that confirmed the stronger
interaction between BRMS1 and N-terminal-deleted importin a6
(Figure 2D). The stability and proper folding of all the tested
Figure 1. NLS1 is necessary and sufficient for nuclear targeting of BRMS1. (A) Schemes of full length (FL) BRMS1, deletion mutants and their
controls (pHM830 and pHM840). Plasmids express a triple GFP/insert/b-Gal fusion protein. (B) Confocal images of U-2 OS transfected cells expressing
GFP-b-Gal NLS constructs. (C) A construct encompassing the residues KRKK from NLS1, resemble the location pattern of the FL. KRKS, represents a
point mutant where the last positively charged residue shifted to uncharged. (D) Total cell lysates from U-2 OS untransfected (mock) or transfected
cells with the indicated constructs were analysed by Western Blotting using an anti-GFP antibody. Molecular markers are shown in kDa.
doi:10.1371/journal.pone.0006433.g001
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monoclonal antibody against the HA tag (Figure 2E).
Altogether, these results support the hypothesis that KPNA5
(importin a6) and not KPNA2 (importin a1) nor KPNA4
(importin a3) specifically might mediate the nuclear transport of
BRMS1 towards the nucleus.
BRMS1 displays nucleo-cytoplasmic shuttling in
heterokaryons
Preliminary results in our lab [8] showed that even though the
majority of the over-expressed BRMS1 protein was present within the
nucleus we repeatedly detected a weak but unambiguous presence of
BRMS1 in the cytosol, suggesting that at least transiently it might play
a functional role in that compartment. Given the fact that we identified
a functional NLS within BRMS1, as shown in Figure 1, and that some
interaction with cytosolic proteins has been observed (Rivera et al.
submitted) and reported [11], we hypothesized that a fraction of the
protein could be exported from the nucleus to the cytosol.
To test this hypothesis we performed an interspecies hetero-
karyon assay, extensively used to assay nuclear protein export
[27,28]. Human HeLa cells transfected with an expression vector
encoding the full-length BRMS1 fused to GFP (pGFP-N1/
BRMS1 FL), were co-cultured with mouse C2C12 cells until
adequately spread. Since cycloheximide was added to the cell
Figure 2. BRMS1 specifically interacts with importin a6i na nin vivo assay. Yeast cells co-transformed with a vector encoding the entire
BRMS1 and a combination of plasmids encoding the complete sequence of importin a6 (KPNA5) or deletion mutants lacking the auto-inhibitory
domains (DKPNA5); importin a1( DKPNA2); or importin a3( DKPNA4), were grown on selective medium (SD-L-T) to assess co-transformation (A) or
plated on highly stringent media (B). Inset shows a clearer picture for growth capacity of different co-transformant yeast indicated in brackets.
Positive control (+) as previously reported [24]. Negative sign (2) indicates co-transformation with an empty vector. Colonies grown on SD-L-T-H,
were assayed for b-Gal activity by a colony lift filter (C) or quantitative liquid assay (D) where activity is represented as a fold induction compare to the
basal activity shown in yeast expressing KPNA5. Error bars represent S.E.M of three independent experiments. (E) Western blot analysis of the
different HA tagged karyopherins probed with anti-HA antibody. Molecular markers are in kDa.
doi:10.1371/journal.pone.0006433.g002
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proteins synthesized prior to cell fusion. Interspecies heterokaryons
were easily distinguishable by their nuclear staining pattern upon
cells analysis by confocal microscope, where human and mouse
nuclei appeared diffusely stained or spotted respectively (Figure 3).
Thirty minutes after heterokaryon formation, the BRMS1-GFP
fusion protein was detected not only in the human but also in the
murine nuclei of fused cells (Figure 3) indicating that BRMS1 can
be exported out of the human nuclei and imported into the mouse
one. In a parallel assay, shuttling of a competent export construct
containing the powerful NES from HIV-1 Rev protein (pRe-
v1.4NES3-eGFP) was observed (Figure 3). Conversely a non-
competent export construct expressing GFP fused to a Rev mutant
[29] remained in the human nuclei (Figure 3), thus confirming that
shuttling of BRMS1 is not due to a diffusion process.
This result suggests that BRMS1 is actively exported from the
nucleus and can translocates from nucleus to cytoplasm although so
far, the endogenous protein has been mainly observed in the nuclei.
Wespeculatethat a prolonged cytosolicpresence ofBRMS1protein
may not be necessary, though a transient cytosolic location is likely
necessary for accomplishing its physiological function.
Identification of a putative nuclear export sequence in
BRMS1
Once the capability to migrate from the nucleus to the cytosol
was assessed, we wondered whether BRMS1 would harbour a
nuclear export sequence (NES).
We inspected its entire amino-acid sequence looking for a leucine, or
any other large hydrophobic rich region similar to those previously
identified as the transport signals that can mediate nuclear export
[30,31]. We noticed a large cluster of hydrophobic residues closely
spaced in the amino terminal half of the protein that would fulfil the
loose consensus of a leucine-rich NES. This result was confirmed after
submission of BRMS1 sequence to the NetNES 1.1 database server
[16]. The server assigned NES score values over the threshold for
residues L
83 to L
88, which in addition to an over-representation of D, E
and S residues suggest that this region conforms to the established
criteria for a NES [30]. As shown in Figure 4 the alignment of all the
BRMS1 orthologs deposited in the databases, identified by blastp
search [32] demonstrates the high conservation of this candidate NES
sequence among the different species,includingthe regularly conserved
spacing between the critical residues for export function.
Analysis of the candidate NES sequence by an in vivo
assay
To test the export activity of the identified candidate NES in
BRMS1, we generated a construct encoding 18 residues
(
74LKEKLFRERLSQLRLRLE
91, hydrophobic residues are un-
derlined) inserted between the export deficient Rev1.4 sequence
and eGFP (Figure 5A), rendering the pRev1.4-BRMS1-eGFP
plasmid. That insert size has been found to be optimal for export
activity [29]. Constructs were transiently over-expressed into
different cell types. The use of Act-D has been reported to prevent
nucleolar accumulation and nuclear import of Rev protein thereby
provoking a cytosolic accumulation of NES-containing protein
[33]. Therefore, we treated transfected cells with Act-D to
facilitate the detection of weak NES signals [29].
Hence, the activity of NES-BRMS1 was evaluated by the ability
of the NES containing fusion protein to shift from the nucleus
towards the cytosol in U-2 OS (Figure 5B) or HeLa (Figure S3)
transfected cells. A cell-counting approach was applied by scoring
cells according to the distribution of the GFP fusion protein as
exclusively nuclear (N), cytosolic (C), or diffuse (N+C) before and
after Act-D treatment. At least 150 cells per sample (431 for
Figure 3. BRMS1 protein migrates between nuclei in interspecies heterokaryon. Human HeLa cells were transfected with a plasmid
encoding the entire BRMS1 sequence (pEGFP-N1/BRMS1), a non-shuttling (pRev1.4-eGFP) or a competent shuttling vector (pRev1.4NES3-eGFP). Then,
HeLa cells were co-cultured with mouse myoblast. After fusion, cells were fixed and stained with Hoescht. Cycloheximide was added to the cell
culture medium before fusion and maintained throughout culture of heterokaryons. Cellular distribution of GFP fusion proteins (top) and nuclear
staining (bottom) were analyzed. Mouse and human nuclei are marked by asterisk and arrowhead respectively. Heterokaryons are marked with a
dashed line. Bar represents 20 mm.
doi:10.1371/journal.pone.0006433.g003
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independent experiments. As expected, the pRev1.4-eGFP negative
control was found exclusively in the nucleus (,97%), whereas the
positive control pRev-NES3-eGFP was detected almost exclusively
(97%) in the cytoplasm upon Act-D treatment (Figure 5B).
In basal conditions, without Act-D treatment, U-2 OS cells
over-expressing NES-BRMS1-eGFP protein displayed a diffuse
N+C staining slightly higher (5.6%) than that found in cells
transfected with pRev1.4-eGFP negative control vector (3.2%),
and clearly less cytoplasmic presence than observed for the positive
control construct (pRev-NES3-eGFP) (Figure 5B). However,
unbiased scoring of more than 400 cells revealed that the
percentage of cells with diffuse N+C staining increased up to
26% following Act-D treatment (Figure 5B), while the negative
control remained at 3% under these conditions.
To determine the relative strength of the BRMS1-NES an
arbitrary scale ranging from 1+ to 9+ (the strongest) was applied
[29]. Our results classify NES-BRMS1 as a very weak signal (+1)
according to this NES scoring system.
Same approach was used with different cell lines (U-2 OS,
HeLa and MDA-MB-231) but only shown in U-2 OS cells
(Figure 5B). Interestingly, the candidate NES from BRMS1
maintained a similar degree of activity in all cell lines tested (data
not shown) indicating that this effect is not cell type specific.
Export of BRMS1 is not CRM1-dependent
CRM1 is an export receptor involved in nucleo-cytoplasmic
exchange of several shuttling proteins [34] capable of binding
cargo molecules containing a canonical NES [15]. To investigate
whether CRM1 is involved in the nuclear export of NES-BRMS1,
human U-2 OS cells transiently expressing the pRev1.4NES
BRMS1-eGFP construct, were treated with the highly specific
CRM1 inhibitor Leptomycin B (LMB). Thirty min later, Act-D
was added to the culture medium to facilitate the detection of
recombinant protein in the cytosol.
A positive control is able to relocate the fusion protein from the
nucleus, even without Act-D treatment, towards the cytoplasm
upon Act-D treatment. Such translocation is abolished when LMB
is added to the culture media (Figure S4). Interestingly, we found
that LMB treatment of cells had no significant effect on nuclear to
cytoplasm shuttling of the reporter protein after transfection of
pRev1.4/NES BRMS1-GFP plasmid (Figure 5C) independently of
the cell type (data not shown) and of the presence or not of Act-D
(Figure 5B). This observation suggests that nuclear export of
BRMS1 is mediated through a CRM1-independent pathway.
Discussion
In this study, we determined the capability of BRMS1 to mediate
nucleo-cytoplasmic shuttling and identified the responsible signals.
Figure 4. BRMS1 comprise a putative NES motif that compare to leucine-rich NES. (A) Schematic representation of the BRMS1 structure
showing the putative NES sequence boundaries identified by NetNES 1.1 server. (B) Alignment of conserved hydrophobic residues (in boxes) from
different BRMS1 orthologs. Numbers refer to amino acid residues. Human putative NES-BRMS1 sequence is compared with known NES, ranging from
highest (MAPKK; PKI and Rev) to the weakest (p53) activity. A generally accepted loose consensus sequence, where X represents any amino acid and
W any large hydrophobic residue (L, I, V, F, M) is shown.
doi:10.1371/journal.pone.0006433.g004
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terized by an in vivo assay. Simultaneous disruption of NLS1+NLS2
abolishes nuclear location of a heterologous protein. Besides, a
construct encompassing both NLS showed an exclusive nuclear
pattern concluding that residues 197–246 are essential for nuclear
location. In addition, this construct displays a stronger fluorescence
within the nucleus compared to BRMS1-FL, suggesting that
conformation of the properly folded (as shown in Figure 1D) FL
fusion protein might somehow impair its nuclear transport, or that
BRMS1 contains another signal(s) able to shuttle the proteinback to
the cytosol. The former observation becomes especially true after
comparisonofthepatternshowedbyaBRMS1proteinmerelyGFP
attached and the very large BRMS1 protein expressed in the
pHM830 system (Figure S1). An NLS1-deletion construct was
Figure 5. BRMS1 contains a functional nuclear export motif independent of CRM1. (A) Scheme of the plasmid system used for testing the
putative BRMS1 NES motif. Disrupted endogenous NES of Rev protein (Rev1.4) allows the in vivo analysis capability of a BamHI/AgeI inserted sequence
fused to eGFP. PCMV: CMV promoter. Representative confocal images of U-2 OS transfected cells with indicated plasmids untreated (2) or treated (+)
with ActD (B) or Act-D + LMB (C). Fixed cells were scored for nuclear (N), citosolic (C) or diffuse (N+C) GFP location. Graphics show mean values of
percentage of positive cells with S.E.M across three independent experiments.
doi:10.1371/journal.pone.0006433.g005
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DNLS2 construct results in the same pattern shown by the FL-
construct, suggesting that NLS2 is dispensable for nuclear
allocation. Altogether we conclude that NLS1 constitute a
functional, necessary and sufficient nuclear signal. A construct
over-expression only four residues (
201KRKK), within NLS1 motif
shifts the fusion protein towards the nucleus as efficiently as the
entire BRMS1 protein. Besides, a substitution of the fourth residue
for an uncharged serine rendered the construct not competent for
nuclear import. Precisely, the KRKS peptide is present within the
NLS2 motif, underscoring its inability for nuclear import.
Our results largely prove the functionality of BRMS1-NLS1 and
the inability of BRMS1-NLS2 as import signals by themselves.
However, it is worth to consider that upon protein folding both
motifs could be brought close enough to allow them to work
cooperatively as a stronger motif. This possibility is endorsed by
the observation of the strongest nuclear localization for a construct
including both motives. It should be noted that our results do not
exclude that BRMS1 could enter the nucleus as part of a complex
with other protein(s).
We also shed light on the mechanism of BRMS1 nuclear
translocation. Analysis of human importins responsible for such
transport concludes that only KPNA5 showed significant interac-
tion with BRMS1 upon a yeast two-hybrid assay. Since KPNA5
has been reported to interact with ANP32A, an acidic phospho-
protein involved in proliferation, differentiation and apoptosis [35]
and with p27Kip1, a cyclin-dependent kinase inhibitor involved in
G1-phase arrest [36] we hypothesized that the KPNA5/BRMS1
complex might also regulate other cellular functions apart from
nuclear import of BRMS1.
Previous reported observations on our lab [8] as well as
transiently BRMS1 over-expressing cells along the present work,
show a consistent and repetitive presence of certain amounts of
BRMS1 in the cytosol. Given that a mechanism for nuclear import
exists, we hypothesized the possibility of an export signal in the
BRMS1 sequence. Computer searching, identified a domain
(residues 74–91) that fulfilled the proposed consensus NES motif
[16]. Score values for important L-residue were above for L
30 in
BRCA1 [37] and L
149 from FGF-1 [38], crucial residues for
export activities. The BRMS1-NES motif is highly conserved,
conforming not only to NES consensus motif but also to well-
known NES sequences. Its functional role was assessed in vivo.
Transfection of human cells with a NES-BRMS1-GFP fusion
construct, showed a slight difference when compared with a non-
competent construct in protein distribution of non-treated cells.
Only 5.6% of transfected cells partially shift fluorescent protein
towards the cytosol while the negative construct show similar
values (3%). However, after inhibition of the nuclear re-import of
NLS-Rev fusion proteins with Act-D, more than 26% of BRMS1-
NES transfected cells showed a partial shift of GFP-protein
towards the cytosol, whereas the non-competent construct
maintained same levels as in non-treated cells. Similar effect was
reported for well-known NES-containing proteins [29]. Scoring of
transfected cells categorize BRMS1-NES as a functional, very low
activity signal, as efficient as p53 and HDM2, but less active than
proteins which completely shift the GFP-fusion protein in the
absence of Act-D.
CRM1 binds cargoes containing a leucine-rich motif, with low
affinity as compared with other exportin receptors [15] ensuring
an efficient release. In order to understand if BRMS1-NES fusion
protein is dependent on CRM1 export, transfected cells were
treated with CRM1 inhibitor, and GFP distribution scored. Cells
transfected with a NES-competent construct completely blocked
the exit of GFP-fusion protein after LMB treatment (Figure S4).
Unexpectedly, subcellular location was unaltered upon treatment
of pRev1.4-BRMS1-NES-eGFP transfected cells. This effect was
maintained when the protein re-import was also blocked by Act-D
in co-treated (LMB+Act-D) cells (Figure 5C). Thus, we conclude
that BRMS1 contains a functional CRM1-independent NES.
Eukaryotic cells separate transcription/replication from trans-
lation by compartmentalization into nucleus and cytosol respec-
tively. The majority of proteins with nuclear function are actively
transported based on its binding to specific karyopherin receptors
usually by the presence of NLS and NES signals. In the absence of
a specific retention mechanism based on the high affinity of a
protein for nuclear components, all nuclear proteins shuttle,
considering export as a default pathway [28]. In such a case the
distribution of a protein will not be directed, at least not
exclusively, by the import/export competence of the protein itself
but also by its capability to bind to nuclear partners. In this sense,
BRMS1 strongly interact with the Sin3-HDAC complex [3,5]
recruiting BRMS1 to specific DNA regions. This interaction
provides a plausible explanation along with the weakness of the
BRMS1-NES for the predominant nuclear location of BRMS1.
The fact that BRMS1 has access to the cytoplasm, even
transiently, might be important for integrating nuclear functions
with those occurring in the cytoplasm, constituting a major event
in the regulation of both activities.
It is worth to mention that apart from being significant for a
better characterization of BRMS1 protein itself, insights into the
mechanism and regulation of its nucleo-cytoplasmic shuttling
capability might be pivotal from the point of view of a potential
clinical/therapeutic approach. Many of reported shuttling proteins
are involved in signalling and cell growth [39,40] and their
incorrect subcellular location related to the development of
different types of cancers [41,42]. As transcription occurs in the
nucleus, the activity of different transcription factors can be
regulated by their subcellular distribution. Thus, identification of
molecules that could affect BRMS1 protein location might prove
effective in controlling cell growth.
In conclusion, our findings suggest that BRMS1 shuttles
between nucleus and cytoplasm mediated by a novel, weak but
functional NES region. Moreover, we provide strong evidence that
NLS1 is necessary and sufficient for BRMS1 nuclear transport.
Finally, the identification of KPNA5 as BRMS1 partner has also
been demonstrated. Since BRMS1 molecular functions are highly
dependent on nuclear localisation, our results possibly suggest
another level of regulation for BRMS1 biological mechanisms.
Future studies should evaluate to what extent the reported nucleo-
cytoplasmic shuttling might affect BRMS1 dependent anti
metastatic properties. We speculate that BRMS1 activity by
import/export transport could serve as a potential regulatory
mechanism playing a biological role which functional/clinical
implications are not yet understood.
Materials and Methods
Cell culture
U-2 OS, HeLa, MDA-MB-23 human and C2C12 mouse
myoblast were from American Type Culture Collection (ATCC).
Cells were grown in Dulbecco’s modified Eagle’s medium (Gibco)
supplemented with 10% foetal bovine serum (EuroClone) in the
presence of penicillin, streptomycin and 2 mM L-glutamine
(Gibco) as recommended. Transfections were performed using
Lipofectamine2000 (Invitrogen). After 24 h, cells were untreated
or treated with Leptomycin B (LMB) (10 ng mL
21) or Actinomy-
cinD (Act-D) (5 mgm L
21) for 3 h. Cycloheximide (15 mgm L
21)
was added 30 min prior additional treatments to ensure that fusion
BRMS1 Nucleo-Cytosol Shuttling
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Sigma.
Heterokaryon assay
HeLa cells grown on cover-slips were transfected with NES-
expression vectors. After 24 h C2C12 mouse cells were co-
cultured for 3 h, cycloheximide was added (100 mgm L
21) for
30 min. Heterokaryons were formed with 50% (w/v) PEG
solution (Sigma-Aldrich; Inc) for 2 min at RT. Subsequently, the
cells were extensively washed, and further incubated at 37uCi n
presence of cycloheximide. The cells were fixed 30 min later with
4% PFA, stained with Hoechst33258 (50 mgm L
21, Sigma-
Aldrich; Inc) and mounted in Mowiol 4–88 (Calbiochem).
Nuclear localization assay
The assay was based on the pHM830 eGFP–b-Galactosidase
triple fusion plasmid [20]. Amplicons obtained by PCR using
specific primers were ligated into pHM830 vector. BRMS1 cDNA
full length clone (IRALp962L0425Q2) was obtained from the
I.M.A.G.E. Consortium [43]. Five different constructs were
engineered encompassing: the entire gene, residues 198–246
containing both putative NLSs (pHM830/NLSs), lacking the 48
(pHM830/DNLSs) or the last 23 C-terminal end residues
(pHM830/DNLS2), and residues from 205 to 246 (pHM830/
NLS2). Numbering is based on human sequence (BC_009834).
More than 200 transfected cells were observed across three
independent experiments.
Nuclear export assay
Nuclear to cytoplasm in vivo assays were carried out as described
[29]. Briefly, mammalian cells were transfected with an export-
defective pRev(1.4)-eGFP protein, a competent nuclear export
construct (pRev1.4-NES3-eGFP) or an engineered construct
encompassing residues 74–91 from BRMS1 (pRev1.4-NES
BRMS1). Relative export activity was measured 24 h later by
scoring nuclear (N), cytosolic (C) or diffuse (N+C) location of fusion
proteins (.200 cells) ranging from 1+ (weakest) to 9+ (strongest)
activity.[29]. Candidate NES insert (residues 74 to 91), was
prepared by annealing specific oligo-deoxy-nucleotides and cloned
as BamHI/AgeI (pRev1.4-NES BRMS1-GFP). Cells were fixed,
mounted and observed 24 h post-transfection.
Fluorescence microscopy
Cells were visualized with a Leica TCS-SP5 confocal laser
microscope equipped with HCX-PL-APO 636lbd.BL (1.4NA) oil-
immersion objectives and UV/argon lasers for DAPI/GFP
detection. Scoring of fusion proteins distribution was as mentioned
above. Independent assays were analyzed with Metamorph
software (Universal Imaging Corp).
Yeast two-hybrid assay
Human BRMS1 entire gene was PCR amplified, cleaved
(EcoRI/PstI), inserted into Gal4-DNA binding domain (BD) of
pAS2.1 (Clontech) vector (pAS2.1/BRMS1) and used as a bait to
test interaction with human a importins fused to the Gal4
activation domain (AD) (pACT2/importin a6; pACT2/importin
a1 and pACT2/importin a3). Deletion mutants for auto-
inhibitory domains (lacking 60 N-terminal residues) were also
generated. PCR-templates were from CNIO collection. Constructs
were co-transformed by lithium acetate into AH109 yeast strain
[44]. Transformant-colonies grown on high stringency selection
media lacking, tryptophan, leucine and histidine (SD-T-L-H) were
subjected to a colony-lift filter assay. Briefly, colonies transferred to
a filter, were disrupted and b-Gal activity detected with Z-buffer
containing 0.27% b-mercaptoethanol and 5-bromo-4-chloro-3-
indolyl-b-D-galactopyranoside. Quantitative activity determina-
tion was performed using o-nitrophenyl-b-D-galactopyranoside
(ONPG). None of the interactions tested were prone to self-
activation. Chemicals and protocols were from Sigma-Aldrich and
Yeast Handbook Clontech respectively.
Supporting Information
Figure S1 Confocal images of GFP distribution after over-
expression in U-2 OS cells of BRMS1 protein merely fused to the
N-terminus of GFP (A) or as fusion protein in the pHM830 triple
fusion plasmid (B).
Found at: doi:10.1371/journal.pone.0006433.s001 (4.25 MB TIF)
Figure S2 A) Fluorescence intensity profile along a line crossing
the cell body of U-2 OS transfected cells with the indicated GFP-
b-Gal NLS constructs. Profiles show intensity of eGFP expression
(green line) and nuclear staining (blue line). Values are normalized
to 1. B) Merged image of DNLSs over-expressing cells where the
intensity profile along a representative area of cell body (dashed
line) is shown as an example. Profiles were recorded using the LAS
AF 1.8.2v acquisition software of a Leica TCS-SP5 confocal
microscope
Found at: doi:10.1371/journal.pone.0006433.s002 (5.93 MB TIF)
Figure S3 Confocal images of transfected HeLa cells expressing
GFP-b-Gal NLS constructs and their controls. Distribution of
GFP fusion proteins is shown. KRKK, represents a construct
encompassing precise residues from NLS1 of BRMS1 protein
resembling the location pattern of the full length (FL). KRKS is a
point mutant where the last positively charged residue shifted to
uncharged, which was unable to relocate the heterologous protein
to the cell nucleus.
Found at: doi:10.1371/journal.pone.0006433.s003 (6.37 MB TIF)
Figure S4 The pRev1.4-eGFP and pRev1.4-NES3-eGFP fusion
proteins were transiently over-expressed in U-2 OS cells. Cell
samples were untreated (-) or treated (+) with LMB to assess
CRM1 transporter inhibition.
Found at: doi:10.1371/journal.pone.0006433.s004 (6.13 MB TIF)
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